| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/07/1999 | EP0906417A1 Cross-linked protein crystal formulations and their use as catalysts in organic solvents |
| 04/07/1999 | EP0906337A2 AN ANTIGENIC EPITOPE OF THE u A /u DETERMINANT OF HEPATITIS B SURFACE ANTIGEN AND USES THEREOF |
| 04/07/1999 | EP0906330A1 STREPTOCOCCUS PNEUMONIAE ISOLEUCYL tRNA SYNTHETASE |
| 04/07/1999 | EP0792458A4 Methods for aiding in the diagnosis of alzheimer's disease by measuring amyloid-beta peptide (x- 41) and tau |
| 04/07/1999 | EP0739419B1 Methods of assaying dna-repairing enzymes and their alkylated derivatives |
| 04/07/1999 | EP0671471B1 Process for producing foreign protein |
| 04/07/1999 | EP0569531B1 Stabilized antibody fragments |
| 04/07/1999 | CN1213406A Method for inhibiting adenylosuccinate synthetase activity methylthioadenosine phosphorylasse deficient cells |
| 04/07/1999 | CN1213401A Exodus chemokine materials and method |
| 04/07/1999 | CN1213380A Peptide immunogens for vaccination against and treatment of allergy |
| 04/07/1999 | CN1213326A Filtration of plasma mixtures using cellulose-based filter aids |
| 04/07/1999 | CN1213312A Anticogulant agent useful in treatment of thrombosis |
| 04/07/1999 | CA2249715A1 Abc transporter |
| 04/06/1999 | US5892020 Multivalent single chain antibodies |
| 04/06/1999 | US5892019 Production of a single-gene-encoded immunoglobulin |
| 04/06/1999 | US5892017 Recombinantly produced pf4ars are used in the preparation and purification of antibodies capable of binding to the receptors, and in diagnostic assays. the antibodies are advantageously used in the prevention and treatment of |
| 04/06/1999 | US5892012 Rab Proteins |
| 04/06/1999 | US5892001 Epithelium-derived T-cell factor antibodies |
| 04/06/1999 | US5892000 From hybridomas 2g6 and b14; for immunoassay test kit used in diagnosis of athlerosclerosis and diabetes |
| 04/06/1999 | US5891997 Receptor for oncostatin M |
| 04/06/1999 | US5891996 Humanized and chimeric monoclonal antibodies that recognize epidermal growth factor receptor (EGF-R); diagnostic and therapeutic use |
| 04/06/1999 | US5891994 Peptides and polypeptides which induce antibodies against hiv-1 tat proteins; for vaccines; diagnosis |
| 04/06/1999 | US5891991 Aplp1 and aplp2 are candidate genes for late onset familial alzheimer's disease. |
| 04/06/1999 | US5891858 Transforming growth factor alpha, treating prostate cancer |
| 04/06/1999 | US5891841 Methods of using intercellular adhesion molecule-3 (ICAM-3), antibodies thereto, and soluble fragments thereof |
| 04/06/1999 | US5891724 Transfecting cell with hybrid nucleic acid |
| 04/06/1999 | US5891706 Hybridoma cell line; therapy and diagnosis of autoimmune skin disorders, antitumor agents |
| 04/06/1999 | US5891700 Receptor-type phosphotyrosine phosphatase-γ |
| 04/06/1999 | US5891678 Isolated polynucleotide encoding bacterial enzyme involved in mediating protein secretion; treatment of invasive infections and toxigenic diseases; antibiotic screening and development |
| 04/06/1999 | US5891675 TNF receptor death domain ligand proteins |
| 04/06/1999 | US5891674 The use of these sequences in the diagnosis, prevention, and treatment of cancer, inflammation, and disorders associated with insulin response. |
| 04/06/1999 | US5891672 Polynucleotides encoding GTP cyclohydrolase II (ribA) |
| 04/06/1999 | US5891670 Tetracycline resistance protein |
| 04/06/1999 | US5891667 SpoIIIe polynucleotides |
| 04/06/1999 | US5891666 Genes encoding LSIRF polypeptides |
| 04/06/1999 | US5891664 Vectors and methods for recombinant production of uPA-binding fragments of the human urokinase-type plasminogen receptor (uPAR) |
| 04/06/1999 | US5891652 Methods of using domains of extracellular region of human platelet-derived growth factor receptor polypeptides |
| 04/06/1999 | US5891651 Methods of recovering colorectal epithelial cells or fragments thereof from stool |
| 04/06/1999 | US5891650 Kinase receptor activation assay |
| 04/06/1999 | US5891647 Using monoclonal antibody |
| 04/06/1999 | US5891642 Method of detecting PHB in human blood serum |
| 04/06/1999 | US5891641 Assay for disease related conformation of a protein |
| 04/06/1999 | US5891640 Peptide derived from human immunodeficiency virus type 1 (HIV-1), isolate ant70, containing an immunodominant epitope and it's use in immunodiagnostic assays |
| 04/06/1999 | US5891638 A method of detecting alk-7 nucleic acid or polypeptide in a sample; and kits containing nucleic acid probes or antibodies. |
| 04/06/1999 | US5891439 Lymphocyte stimulating factor |
| 04/06/1999 | US5891438 Method for stimulating production of variable region gene family restricted antibodies through B-cell superantigen vaccination |
| 04/06/1999 | US5891437 Antigen associated with type I diabetes mellitus |
| 04/06/1999 | US5891434 Monoclonal antibodies to the APO-1 antigen |
| 04/06/1999 | CA2107567C Detection of cardiovascular lesions |
| 04/06/1999 | CA2095836C Cytokine immunoconjugates |
| 04/06/1999 | CA1340485C Peptide analogs and their use as haptens to elicit catalytic antibodies |
| 04/06/1999 | CA1340483C Diagnosis of retinoblastoma |
| 04/01/1999 | WO1999015904A1 Methods and compositions for diagnosing renal pathologies |
| 04/01/1999 | WO1999015896A1 Homogeneous method for detecting and/or determining phosphorylating activity in a biological material |
| 04/01/1999 | WO1999015694A1 Coreactant-including electrochemiluminescent compounds, methods, systems and kits utilizing same |
| 04/01/1999 | WO1999015692A2 Dengue virus antigens and treatment of dengue fever |
| 04/01/1999 | WO1999015675A1 HUMAN COMPLEMENT C3-DEGRADING PROTEINASE FROM $i(STREPTOCOCCUS PNEUMONIAE) |
| 04/01/1999 | WO1999015671A1 Hepatitis b virus polypeptides |
| 04/01/1999 | WO1999015664A1 Insulin-like polypeptide and uses therefor |
| 04/01/1999 | WO1999015663A1 Novel molecules of the tnf receptor superfamily and uses therefor |
| 04/01/1999 | WO1999015661A1 Cell growth regulator |
| 04/01/1999 | WO1999015660A1 G-protein coupled glycoprotein hormone receptor hg38 |
| 04/01/1999 | WO1999015658A2 Human regulatory molecules |
| 04/01/1999 | WO1999015657A2 53bp2 complexes |
| 04/01/1999 | WO1999015656A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 04/01/1999 | WO1999015654A2 Tie receptor tyrosine kinase ligand homologues |
| 04/01/1999 | WO1999015653A2 Tie ligand homologues |
| 04/01/1999 | WO1999015647A1 A potential effector for the grb7 family of signalling proteins |
| 04/01/1999 | WO1999015635A1 Human ste20-like stress activated serine/threonine kinase |
| 04/01/1999 | WO1999015563A1 Catalytic antibodies and a method of producing same |
| 04/01/1999 | WO1999015558A1 Warts protein, polynucleotide encoding the same, antisense polynucleotide thereof, and antibody recognizing the protein |
| 04/01/1999 | WO1999015553A2 Costimulating t-cell polypeptide, monoclonal antibodies, their preparation and use |
| 04/01/1999 | WO1999015550A1 Ucp3 genes |
| 04/01/1999 | WO1999015549A2 Peptide sequences as hinge regions in proteins like immunoglobulin fragments and their use in medicine |
| 04/01/1999 | WO1999015541A2 Use of a pentopyranosyl nucleoside for producing an electronic component, and conjugates of said pentopyranosyl nucleoside |
| 04/01/1999 | WO1999015540A2 Method for producing a pentopyranosyl nucleoside |
| 04/01/1999 | WO1999015539A2 Pentopyranosyl nucleoside, and production and use of the same |
| 04/01/1999 | WO1999015200A1 MEDICINAL COMPOSITION CONTAINING gp34 BINDING INHIBITOR AS THE ACTIVE INGREDIENT |
| 04/01/1999 | WO1999015198A2 Agents for combating bacterial meningitis |
| 04/01/1999 | WO1999015158A2 REGULATION OF CELLULAR APOPTOSIS USING MODULATORS OF β-AR RECEPTORS |
| 04/01/1999 | WO1999002567A3 Compositions and methods for producing homoconjugates of antibodies which induce growth arrest or apoptosis of tumor cells |
| 04/01/1999 | WO1999002564A3 Ancrod specific monoclonal antibodies, antibody fragments, mixtures or derivatives thereof and use of the same |
| 04/01/1999 | WO1999002545A3 Antigen binding fragments, designated 4b5, that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 04/01/1999 | WO1998055615A9 Apaf-1, the ced-4 human homolog, an activator of caspase-3 |
| 04/01/1999 | WO1998054577A9 Cyclic peptide libraries and methods of use thereof to identify binding motifs |
| 04/01/1999 | WO1998051824A9 Reagents and methods useful for detecting disease of the urinary tract |
| 04/01/1999 | WO1998051787A3 Gene construct encoding a heterologous prodrug-activating enzyme and a cell targeting moiety |
| 04/01/1999 | WO1998051321A9 Tissue factor for influencing blood vessel formation |
| 04/01/1999 | WO1998050554A3 Enterococcus faecalis polynucleotides and polypeptides |
| 04/01/1999 | WO1998044948B1 Intravenous immune globulin formulation containing a non-ionic surface active agent with improved pharmacokinetic properties |
| 04/01/1999 | WO1998039363A3 Immunotoxins and methods of inducing immune tolerance |
| 04/01/1999 | WO1998014592A3 Telomerase reverse transcriptase |
| 04/01/1999 | DE19741955A1 Mittel gegen bakterielle Meningitis Medicines for bacterial meningitis |
| 04/01/1999 | CA2305350A1 Costimulating polypeptide of t cells, monoclonal antibodies, and the preparation and use thereof |
| 04/01/1999 | CA2305016A1 Human complement c3-degrading proteinase from streptococcus pneumoniae |
| 04/01/1999 | CA2304843A1 Regulation of cellular apoptosis using modulators of .beta.-ar receptors |
| 04/01/1999 | CA2304828A1 G-protein coupled glycoprotein hormone receptor hg38 |
| 04/01/1999 | CA2304793A1 Warts protein, polynucleotide encoding the same, antisense polynucleotide thereof, and antibody recognizing the protein |
| 04/01/1999 | CA2304746A1 Novel molecules of the tnf receptor superfamily and uses therefor |
| 04/01/1999 | CA2304615A1 Agents for combating bacterial meningitis |